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ABSTRACT The current study evaluated the effects
of different inclusion levels of microbial muramidase
(Muramidase 007, DSM Nutritional Products) on gas-
trointestinal functionality by determination of appar-
ent ileal digestibility (AID) of nutrients, investigation
of intestinal histomorphology, and quantification of re-
sulting growth performance. Four maize-wheat-soybean
experimental diets were produced without (C) and
with different dosages of muramidase: low (L, 25,000
LSU(F)/kg), medium (M, 35,000 LSU(F)/kg), and high
(H, 45,000 LSU(F)/kg); diets were fed to broilers for 35
d. At the end of the experiment, AID of ether extract
(EE), crude protein (CP), Ca, and P were determined
and samples of the mid-jejunum and -ileum were col-
lected for histomorphological observations. Data were
subjected to ANOVA analysis using the GLM proce-
dure. Orthogonal polynomial contrasts were used to as-
sess linear and quadratic effects of different levels of the
muramidase. At the end of the trial, Muramidase 007
supplementation linearly increased body weight gain
and decreased feed conversion ratio (FCR) (P ≤ 0.05).
Adding the muramidase to broiler diets also linearly
increased the European poultry efficiency factor (P ≤
0.05). Inclusion of the muramidase in broiler diets lin-
early increased AID of CP, EE, and P (P ≤ 0.05), and
the H group had a higher AID of EE and CP compared
to C group (P ≤ 0.05). Microbial muramidase supple-
mentation linearly increased ileal villus length to crypt
depth ratio and decreased the number of ileal CD45
cells (P ≤ 0.05). Broilers fed M and H diets had fewer
number of CD45 cells in the ileum compared to those
in C group (P ≤ 0.05). In conclusion, the results of the
present study demonstrated that inclusion of the micro-
bial muramidase in broiler diets could increase AID of
key nutrients and improve growth performance in broil-
ers. Adding microbial muramidase to broiler diets can
therefore be considered as an interesting prospect to
improve gastrointestinal functionality. Biological mech-
anisms causing these improvements need to be studied
further.
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INTRODUCTION
An effective functionality of the gastrointestinal (GI)
tract and its health are key determinants in achieving
feed efficiency, animal welfare, and sustainability (Celi
et al., 2017). Peptidoglycans (PGNs) are components
forming the cell wall of bacteria, and considered as con-
served products of bacterial metabolism and activity
in the GI tract. While there is a massive turnover of
PGNs from the bacterial cell wall fragments in the gut
during the natural bacterial cell wall recycling, it has
been reported that PGNs can have a pro-inflammatory
impact on the GI tract of host (Linskens et al., 2001;
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Kyburz et al., 2003; Mayer, 2012; Wheeler et al., 2014).
Muramidase (EC 3.2.1.17), also known as lysozyme
or N-acetylmuramidase, is a glycosyl hydrolytic en-
zyme, which cleaves the β-1, 4 glycosidic linkages be-
tween N-acetylmuramic acid and N-acetyl glucosamine
in the carbohydrate backbone of bacterial PGNs. Main
PGNs breakdown products are muropeptides that have
been reported to modulate inflammatory response in
the GI tract of different species. However, the magni-
tude and type of inflammatory responses modulated
by muropeptides depend on the species and cell type
(Traub et al., 2006). Muramidases are ubiquitous. The
most known muramidase is the one abundantly found
in hen egg white (HEW), but various muramidases can
be found in different types of animal secretions, plants,
or microorganisms (Lichtenberg et al., 2017). Studies
on pig and poultry reported the beneficial impacts of
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feeding HEW lysozyme on the gut microbiota, including
a reduction in pathogenic bacteria e.g., Clostridium per-
fringens, Escherichia coli, etc., on the GI tract antioxi-
dant status, including an increase in gene expression of
intestinal glutathione peroxidase, and on the GI tract
nonspecific immunity, including an increase in gene
expression of intestinal interferon-gamma, inteleukin-
10 and 18 (Liu et al., 2010; Oliver and Wells, 2015;
Long et al., 2016; Abdel-Latif et al., 2017; Gong et al.,
2017; Ma et al., 2017). Given the observed impacts of
muramidase in poultry and pig nutrition, it can be
hypothesized that inclusion of microbial muramidase
in broiler diets may improve GI functionality, which
finally can lead to better nutrient digestibility and
absorption and higher growth performance. Recently,
it has been demonstrated that the supplementation of
a dietary microbial muramidase in broilers diets im-
proved growth performance and increased the number
of Lactobacillus spp. in the cecum of broilers (Lichten-
berg et al., 2017).
The present study aimed to investigate the impacts of
different inclusion levels of microbial muramidase on GI
functionality by measuring apparent ileal digestibility
(AID) of nutrients, examination of intestinal histology,
and quantification of resulting animal growth and feed
efficiency.
MATERIALS AND METHODS
Animals and Experimental Design
The animal trial was conducted in accordance with
the Animal Welfare Act of Germany approved by the
local state office of occupational health and techni-
cal safety (Landesamt fu¨r Gesundheit und Soziales,
LaGeSo, no. A 0100/13).
Four starter (day 1 to 21) and 4 grower (day 22 to 35)
maize-wheat-soybean diets were produced without (C)
and with different levels of Muramidase 007 (microbial
muramidase); low (L, 25,000 LSU(F)/kg), medium (M,
35,000 LSU(F)/kg), and high (H, 45,000 LSU(F)/kg).
The tested muramidase product was included as dry
commercial formulated form, and it had an analyzed
muramidase activity of 65,500 LSU(F)/g product. No
antibiotic was supplemented during the experimental
period. The diets were isocaloric and isonitrogenous for
each feeding phase and meet or exceed the recommen-
dations of the Society of Nutritional Physiology (GfE,
1999). The grower diets contained 3 g titanium dioxide
(TiO2) per kg feed (Sigma Aldrich, St. Louis, MO) as
an indigestible marker to allow for the determination of
AID of nutrients. The compositions of the starter and
grower diets are shown in Tables 1 and 2, respectively.
A total of 960 one-day-old male broiler chickens
(Cobb) were obtained from a local hatchery (Cobb
Germany Avimex GmbH) and were randomly allo-
cated to 48 pens (3.1 m2) with bedding of softwood
shaving such that there were 240 birds per treatment,
20 chickens per replicate pen, and 12 replicate pens per
treatment.
The temperature was 33◦C for the first 7 d of the
experiment, after which the temperature was gradually
reduced by 3◦C per week until reaching 22◦C. The ar-
tificial light (45 lux) during the first 4 d of age was
provided for 24 h continuously. From day 5 of age on-
wards, the lighting regime consisted of an 18-h light
and 6-h dark cycle. The animals had ad libitum ac-
cess to feed (mash form) and water throughout the
experiment.
Performance Measurements
Body weights of the chicks and their feed intakes (FI)
were recorded weekly, and body weight gain (BWG),
FI, and feed conversion ratio (FCR) for day 7, 21, and
35 were calculated. The overall European poultry effi-
ciency factor (EPEF) was calculated as follows:
EPEF = (Average daily weight gain× survival rate)
÷ feedconversion ratio× 10
The data are presented in Table 3.
Nutrient Digestibility
At the end of the experiment, 3 birds per pen were
randomly selected, the ileal digesta was collected from
the posterior half between Meckel’s diverticulum and
3 cm cranial to the ostium ileocecale for AID deter-
minations. The digesta of all birds within each pen
was pooled, immediately frozen (–20◦C) and stored un-
til further analysis (ether extract [EE], crude protein
[CP], Ca, and P). The pooled digesta was freeze-dried
before chemical analysis.
The following formula was used for AID calculation:
[
AID (%) = 100− % Marker in feed
% Marker in the ileum
× % Nutrient in the ileum
% Nutrient in feed
× 100
]
The AID of nutrients is shown in Table 4.
Intestinal histology
At the end of the experiment, intestinal samples were
also taken for histomorphological studies. For this pur-
pose, 8 pens out of 12 were randomly selected and sam-
ples from mid-jejunum and -ileum of 1 broiler chicken
(with a body weight close to the mean body weight
of the corresponding pen) per pen were taken. The
samples were rinsed with Ringer’s solution and cut
into 3 pieces each. The samples were placed in his-
tology cassettes and immediately fixed for 24 h in a
4% phosphate-buffered formaldehyde solution at room
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Table 1. Ingredients and nutritional characteristics of the starter diets from day 1 to 21 of age (as is).
Treatment groups1 Control Low Medium High
Ingredients
Maize g/kg 319.7 319.7 319.7 319.7
Soybean meal (CP 47%) g/kg 333.1 333.1 333.1 333.1
Wheat g/kg 252 252 252 252
Soybean oil g/kg 52 52 52 52
Limestone g/kg 10.3 9.9 9.8 9.6
Monocalcium-phosphate g/kg 15 15 15 15
Premix2 g/kg 12 12 12 12
DL-Methionine g/kg 3.1 3.1 3.1 3.1
L-Lysine HCL g/kg 1.9 1.9 1.9 1.9
L-Threonine g/kg 0.9 0.9 0.9 0.9
Muramidase 007 g/kg 0 0.382 0.534 0.687
Analyzed nutrient composition
AMEn3 MJ/kg 12.42 12.42 12.42 12.42
Crude protein g/kg 219.0 218.9 219.3 218.7
Crude fiber g/kg 27.1 26.7 26.9 26.5
Ether extract g/kg 74.3 75.1 74.7 74.8
Starch g/kg 367.7 368.3 367.4 366.9
Sugars g/kg 43.2 42.7 42.9 43.4
Ca g/kg 9.3 9.3 9.2 9.2
P (total) g/kg 7.4 7.5 7.4 7.3
Na g/kg 1.8 1.7 1.8 1.7
Xylanase BXU4/kg 16,112 16,208 16,088 16,111
Phytase FTU5/kg 691 684 676 680
Muramidase LSU(F)6/kg 1863 25,067 30,305 39,833
1Control: control diet, low (25,000 LSU(F)/kg muramidase), medium (35,000 LSU(F)/kg muramidase), high (45,000
LSU(F)/kg muramidase).
2Contents per kg Premix: 600,000 I.U. Vit. A (acetate); 120,000 I.U. Vit. D3; 6,000 mg Vit. E (α-tocopherole acetate);
200 mg Vit. K3 (MSB); 250 mg Vit. B1 (mononitrate); 420 mg Vit. B2 (cryst. riboflavin); 300 mg Vit. B6 (pyridoxin-HCl);
1,500 μg Vit. B12; 3,000 mg niacin (niacinamide); 12,500 μg biotin (commercial, feed grade); 100 mg folic acid (cryst.,
commercial, feed grade); 1,000 mg pantothenic acid (Ca d-pantothenate); 60,000 mg choline (chloride); 5,000 mg iron
(iron carbonate); 5,000 mg zinc (zinc sulfate); 6,000 mg manganese (manganous oxide); 1,000 mg copper (copper oxide);
45 mg iodine (calcium-iodate); 20 mg selenium (sodium-selenite); 140 g sodium (NaCl); 55 g magnesium (magnesium
sulfate); carrier: calcium carbonate (calcium min 38%); Quantum Blue 5G: 41,666 FTU/g; Econase XT 5P:133,333
BXU/g; Monteban G100: 5,833 mg; 5P:133’3333 BXU.
3Nitrogen-corrected apparent metabolizable energy estimated from chemical composition of feed ingredients (based
on the EU Regulation—Directive 86/174/EEC): 0.1551 × % crude protein + 0.3431 × % ether extract + 0.1669 × %




temperature. Fixed tissues were dehydrated in graded
series of ethanol, embedded in paraffin, cut to 5 μm
thin sections, put on slides, de-waxed in xylene, rehy-
drated, and stained accordingly to H&E or AB/PAS
standard staining protocols. For each sample, 3 to 6
slides were prepared and examined under a light micro-
scope (Nikon, Tokyo, Japan). The digitalized live pic-
tures were transferred to a computer monitor and an-
alyzed employing the computer-assisted image analysis
program NIS-Elements AR (Nikon Instruments INC.).
Villus length and crypt depth were measured on the
H&E samples with ×50 magnification. Only parts of
the sections were measured, where villi were cut com-
pletely from top to bottom and the most crypts were
also cut vertically. Villus length was defined as the dis-
tance from the tip of the villus to the villus–crypt junc-
tion. The crypt depth was determined as the distance
from the villus–crypt junction to the crypt´s base. In
total, 20 villi and crypts were measured per sample and
the mean values were taken for further calculations. The
ratio of villus length to crypt depth (VLCDR) was cal-
culated.
The number of goblet cells was counted on the
AB/PAS samples with ×600 magnification. They were
detected via a color threshold with the automatic count-
ing tool. A region of interest (ROI) within the field
of view was defined. Fields were only measured, if the
epithelium was cut tangentially on the level of the gob-
let cells and filled the whole ROI. Ten fields were mea-
sured per sample. For immunohistochemical detection
of CD45-positive cells (leukocytes), mouse anti-chicken
CD45 PE (Southern Biotech, Birmingham, UK, Cat
No 8270–09, Clone LT40) was used. Mouse IgM-PE
(Southern Biotech, Birmingham, UK, Cat No 0101–09)
was used as the isotype control. The number of CD45-
positive cells in the epithelium was measured on the
samples with ×600 magnification. They were detected
via a color threshold with the automatic counting tool.
An ROI within the field of view was defined. Fields
were only measured, if the epithelium was cut tangen-
tially and filled the whole ROI. A total of 30 fields were
measured per sample to cover all levels within the ep-
ithelium homogeneously (above, on the level, and under
the nucleus). Results for goblet cells and CD45-positive
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Table 2. Ingredients and nutritional characteristics of the grower diets from day 22 to 35 of age (as is).
Treatment groups1 Control Low Medium High
Ingredients
Maize g/kg 308.7 308.7 308.7 308.7
Wheat g/kg 295.7 295.7 295.7 295.7
Soybean meal (CP 47%) g/kg 293 293 293 293
Soybean oil g/kg 58 58 58 58
Limestone g/kg 10.3 9.9 9.8 9.6
Monocalcium phosphate g/kg 13.8 13.8 13.8 13.8
Premix2 g/kg 12 12 12 12
Titanium(IV) dioxide g/kg 3 3 3 3
L-Lysine HCL g/kg 2.3 2.3 2.3 2.3
DL-Methionine g/kg 2.3 2.3 2.3 2.3
L-Threonine g/kg 0.9 0.9 0.9 0.9
Muramidase 007 g/kg 0 0.382 0.534 0.687
Analyzed nutrient composition
AMEn3 MJ/kg 12.73 12.73 12.73 12.73
Crude protein g/kg 200.7 201.3 200.8 201.0
Crude fiber g/kg 25.5 25.3 25.0 25.9
Ether extract g/kg 80.2 79.7 78.3 79.0
Starch g/kg 402.5 403 402.7 384.2
Sugars g/kg 40.6 39.7 40.2 39.5
Ca g/kg 8.6 8.6 8.5 8.5
P (total) g/kg 7.0 6.8 6.7 6.8
Na g/kg 1.6 1.6 1.7 1.7
Xylanase BXU4/kg 16,231 16,188 16,203 16,172
Phytase FTU5/kg 679 692 681 676
Muramidase LSU(F)6/kg 1,850 26,158 37,605 41,496
1Control: control diet, low (25,000 LSU(F)/kg muramidase), medium (35,000 LSU(F)/kg muramidase), high (45,000
LSU(F)/kg muramidase).
2Contents per kg Premix: 600,000 I.U. Vit. A (acetate); 120,000 I.U. Vit. D3; 6,000 mg Vit. E (α-tocopherole acetate);
200 mg Vit. K3 (MSB); 250 mg Vit. B1 (mononitrate); 420 mg Vit. B2 (cryst. riboflavin); 300 mg Vit. B6 (pyridoxin-HCl);
1,500 μg Vit. B12; 3,000 mg niacin (niacinamide); 12,500 μg biotin (commercial, feed grade); 100 mg folic acid (cryst.,
commercial, feed grade); 1,000 mg pantothenic acid (Ca d-pantothenate); 60,000 mg choline (chloride); 5,000 mg iron
(iron carbonate); 5,000 mg zinc (zinc sulfate); 6,000 mg manganese (manganous oxide); 1,000 mg copper (copper oxide);
45 mg iodine (calcium-iodate); 20 mg selenium (sodium-selenite); 140 g sodium (NaCl); 55 g magnesium (magnesium
sulfate); carrier: calcium carbonate (calcium min 38%); Quantum Blue 5G: 41,666 FTU/g; Econase XT 5P:133,333
BXU/g; Monteban G100: 5,833 mg; 5P:133’3333 BXU.
3Nitrogen-corrected apparent metabolizable energy estimated from chemical composition of feed ingredients (based
on the EU Regulation—Directive 86/174/EEC): 0.1551 × % crude protein + 0.3431 × % ether extract + 0.1669 × %




cells were expressed as cells per 0.1 mm2 of epithelial
area. The data are presented in Table 5.
Chemical analysis
Chemical analysis of feed samples included Weende
constituents and also calcium, phosphorus, and sodium.
Analyses were in accordance to the methods issued by
VDLUFA (2003) and were as follows, dry matter: VDL-
UFA III 3.1; CP: VDLUFA III 4.1.1 modified according
to macro-N determination (vario Max CN); crude fiber:
VDLUFA III 6.1.4; EE: VDLUFA III 5.1.1; starch: VD-
LUFA III 7.2.1; total sugars: VDLUFA III 7.1.1; Ca:
VDLUFA VII 2.2.2.6; P: VDLUFA VII 2.2.2.6; Na: VD-
LUFA VII 2.2.2.6. Titanium dioxide content was mea-
sured using the method described by Short et al. (1996).
The muramidase activity of feed samples was deter-
mined according to the method described by Lichten-
berg et al. (2017). The ileal pooled digesta was also
analyzed for EE, CP, Ca, P, and TiO2 content, using
the same methods mentioned above.
Statistical Analysis
Data were subjected to ANOVA using the GLM
procedure of SPSS 21.0 (SPSS Inc., Chicago, IL).
Treatment means were separated by the Tukey least
significant difference post hoc test at P ≤ 0.05 sta-
tistical level. Orthogonal polynomial contrasts were
used to examine linear and quadratic effects of dif-
ferent inclusion levels of the muramidase. The repli-
cate pen was the experimental unit for all variables
measured.
RESULTS
Results of analyses of the muramidase activity in the
diets confirmed the correct addition of the test products
within the range of the expected values ± 20% (Tables 1
and 2).
In the first week of age, adding muramidase to broiler
diets linearly improved BWG and FCR (P < 0.001
and P = 0.012, respectively), and birds fed the high-
est dosage of muramidase had better BWG and FCR
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Table 3. Effect of different inclusion levels of muramidase on growth performance∗ of broiler chickens.
P value
Treatment groups1 Control Low Medium High Linear Quadratic
First week (day 1 to 7 of age)
Body weight gain g 100 ± 3a 102 ± 2a,b 102 ± 2a,b 104 ± 2.9b 0.003 <0.001 0.853
Feed intake g 112 ± 6 110 ± 5 110 ± 3 111 ± 2.9 0.722 0.655 0.362
Feed conversion ratio2 1.117 ± 0.059a 1.080 ± 0.046a,b 1.082 ± 0.032a,b 1.066 ± 0.038b 0.049 0.012 0.419
Starter period (day 1 to 21 of age)
Body weight gain g 871 ± 20 881 ± 19 884 ± 18 881 ± 17 0.350 0.163 0.249
Feed intake g 1058 ± 26 1051 ± 28 1052 ± 22 1047 ± 18 0.727 0.288 0.922
Feed conversion ratio2 1.215 ± 0.029a 1.194 ± 0.014a,b 1.190 ± 0.017b 1.188 ± 0.018b 0.009 0.003 0.116
Grower period (day 22 to 35 of age)
Body weight gain g 1301 ± 57 1333 ± 44 1333 ± 30 1334 ± 35 0.156 0.069 0.211
Feed intake g 1972 ± 103 1966 ± 70 1954 ± 51 1952 ± 42 0.882 0.432 0.916
Feed conversion ratio2 1.518 ± 0.073a 1.475 ± 0.022a,b 1.466 ± 0.029b 1.463 ± 0.031b 0.013 0.004 0.119
Overall period (day 1 to 35 of age)
Body weight gain g 2172 ± 51 2214 ± 47 2217 ± 37 2216 ± 34 0.060 0.018 0.087
Feed intake g 3030 ± 113 3017 ± 78 3006 ± 61 2999 ± 42 0.775 0.301 0.900
Feed conversion ratio2 1.395 ± 0.043a 1.363 ± 0.015b 1.356 ± 0.023b 1.354 ± 0.016b 0.001 <0.001 0.008
EPEF3 443 ± 18.1b 463 ± 10.0a 467 ± 11.9a 467 ± 11.1a <0.001 <0.001 0.421
1Control: control diet, low (25,000 LSU(F)/kg muramidase), medium (35,000 LSU(F)/kg muramidase), high (45,000 LSU(F)/kg muramidase).
2g feed per g body weight gain.
3 European poultry efficiency factor: averaged grams gained per day × survival rate (%) ÷ feed conversion ratio × 10.
∗Data are means of 12 replicate pens with 20 birds per pen.
a,bDifferent superscripts within lines indicate levels of significance at P ≤ 0.05.
Table 4. Effect of different inclusion levels of muramidase on apparent ileal digestibility of nutrients∗ in
broiler chickens at day 35 of age.
P value
Treatment groups1 Control Low Medium High Linear Quadratic
Crude protein % 72.8 ± 4.05b 74.7 ± 4.17a,b 76.6 ± 3.12a,b 77.5 ± 2.80a 0.011 0.001 0.606
Ether extract % 91.3 ± 1.49b 91.5 ± 1.49a,b 92.9 ± 1.78a,b 93.1 ± 1.46a 0.009 0.002 0.955
Ca % 53.9 ± 1.38 53.9 ± 1.30 54.3 ± 1.46 54.8 ± 1.53 0.381 0.100 0.580
P % 60.9 ± 2.74 62.0 ± 2.93 62.8 ± 2.28 63.7 ± 1.89 0.055 0.007 0.722
1Control: control diet, low (25,000 LSU(F)/kg muramidase), medium (35,000 LSU(F)/kg muramidase), high (45,000
LSU(F)/kg muramidase).
∗Data are means of 12 replicate pens, 3 birds per pen.
a,bDifferent superscripts within lines indicate levels of significance at P ≤ 0.05.
compared with C group (P = 0.003 and P = 0.049,
respectively). At the end of the starter and grower pe-
riods, inclusion of muramidase to broiler diets linearly
decreased FCR (P = 0.003 and P = 0.004, respectively),
and birds fed M and H diets had better FCR compared
with those received C diet (P = 0.009 and P = 0.013,
respectively). At the end of the experiment, murami-
dase supplementation linearly improved BWG and FCR
(P = 0.018 and P < 0.001, respectively), and birds in L,
M, and H groups had lower FCR compared with those
in C group (P = 0.001). Muramidase supplementation
also showed quadratic decrease in cumulative FCR at
day 35 (P = 0.008). The EPEF standardizes technical
results with taking into account feed conversion ratio,
mortality, and daily weight gain. Supplementation of
broiler diets with muramidase linearly increased EPEF
(P < 0.001) and broilers fed L, M, and H diets had bet-
ter EPEF compared with those fed C diet (P = 0.001).
Except for cumulative BWG at day 35, inclusion of dif-
ferent levels of muramidase into broiler diets had no
impact on FI and BWG of broilers during the starter,
grower, and entire experimental periods (P > 0.05).
Adding muramidase to broiler diets linearly improved
AID of CP and EE (P = 0.001 and P = 0.002, re-
spectively), and broilers receiving the highest dosage
of muramidase had remarkably better AID of CP and
EE compared with C group (P = 0.011 and P = 0.009,
respectively). There were no significant differences be-
tween experimental groups for AID of Ca (P > 0.05),
while inclusion of muramidase to broiler diets linearly
increased AID of P (P = 0.007).
Muramidase inclusion in broiler diets linearly in-
creased VLCDR and decreased number of CD45 cells
in the ileum (P = 0.045 and P = 0.003, respectively).
Inclusion of medium and high dosages of Muramidase
007 in broiler diets resulted in a reduction in number
of CD45 cells in the ileum (P ≤ 0.05). However, the
number of CD45 cells in the ileum of broilers fed L
diet was similar to the other 3 groups. The histolog-
ical evaluations did not reveal any other considerable
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Table 5. Effect of different inclusion levels of muramidase on morphometry and immunohistochemically analysis∗ in the mid-jejunum
and -ileum of broiler chickens at day 35 of age.
P value
Treatment groups1 Control Low Medium High Linear Quadratic
Mid-jejunum
Villi length μm 1239 ± 318 1358 ± 437 1371 ± 209 1481 ± 154 0.468 0.131 0.962
Crypt depth μm 142 ± 13 149 ± 34 157 ± 28 161 ± 33 0.558 0.160 0.883
Villi length/crypt depth 8.7 ± 2.35 9.6 ± 3.31 8.9 ± 1.34 9.4 ± 1.36 0.840 0.744 0.820
CD45-positive cells n/0.1 mm2 372 ± 66 362 ± 82 350 ± 33 405 ± 120 0.584 0.524 0.267
Goblet cells n/0.1 mm2 605 ± 129 633 ± 243 635 ± 78 706 ± 91 0.588 0.212 0.688
Mid-ileum
Villi length μm 808 ± 112 882 ± 149 877 ± 115 903 ± 76 0.400 0.136 0.561
Crypt depth μm 117 ± 4 122 ± 13 116 ± 3 115 ± 5 0.234 0.242 0.297
Villi length/crypt depth 6.9 ± 1.15 7.2 ± 0.88 7.6 ± 1.06 7.9 ± 0.88 0.244 0.045 0.978
CD45-positive cells n/0.1 mm2 462 ± 54a 396 ± 61a,b 338 ± 78b 363 ± 81b 0.008 0.003 0.074
Goblet cells n/0.1 mm2 1020 ± 78 984 ± 144 957 ± 83 946 ± 97 0.501 0.141 0.730
1Control: control diet, low (25,000 LSU(F)/kg muramidase), medium (35,000 LSU(F)/kg muramidase), high (45,000 LSU(F)/kg muramidase).
∗Data are means of 8 replicate-pens, 1 bird per pen.
a,bDifferent superscripts within lines indicate levels of significance at P ≤ 0.05.
impact either on the morphometric values or on the
quantity of the lymphocytes (CD45) or goblet cells
(P > 0.05).
DISCUSSION
In the present study, inclusion of Muramidase 007
in broiler diets linearly increased BWG and decreased
FCR at the early life stage of chickens (P ≤ 0.05).
However, at the end of the experiment, inclusion of
the muramidase could linearly improve the cumula-
tive FCR, BWG, and EPEF (P ≤ 0.05). The results
are in agreement with data from Lichtenberg et al.
(2017), where inclusion of 45,000 LSU(F)/kg (686 ppm)
of microbial muramidase (Muramidase 007) to the di-
ets of broilers improved FCR at the end of the study
(day 42). Similarly, other studies on the use of mu-
ramidase from different origins, e.g., modified rice ex-
pressing lysozyme (Humphrey et al., 2002) or HEW
lysozyme (Abdel-Latif et al., 2017), in poultry diets
have also reported improvement in feed efficiency. In
contrast, adding 100 ppm HEW lysozyme preparation
(4800 units/mg enzymatic activity) to broiler diets had
no effects on BWG and FCR at different life stages
of healthy chickens (Gong et al., 2017). In C. perfrin-
gens challenge studies showed dietary HEW lysozyme
improved growth performance of broiler chickens as
compared with challenged birds in control group (not
provided with lysozyme), but not compared with un-
challenged birds (Liu et al., 2010; Zhang et al., 2010).
The histomorphological evaluation of jejunum in the
present study showed no impact on the morphometric
variables as well as the quantity of the lymphocytes
(CD45) or goblet cells. However, in the ileum, the mu-
ramidase supplementation linearly increased VLCDR
and decreased number of CD45 cells (P ≤ 0.05). Data
regarding the effect of microbial muramidase on intesti-
nal histomorphology of broilers and pigs are limited,
and reported results on non-microbial muramidase have
been inconsistent. In a study conducted by Humphrey
et al. (2002), chickens fed a conventional diet containing
10% modified rice expressing lysozyme showed longer
villi in the duodenum but not in the ileum, while the
number of leukocytes in their ileal lamina propria de-
creased. However, inclusion of HEW lysozyme in broiler
diets increased villi length and crypts depth in the je-
junum (Abdel-Latif et al., 2017). Supplementation of
weaning piglet diets with 90 mg/kg HEW lysozyme in-
creased VLCDR in the duodenum and jejunum, while
it had no effect on villus length and crypt depth in
the duodenum, jejunum, and ileum (Long et al., 2016).
Supplementation of milk replacer (for weaning piglets)
with liquid HEW lysozyme (100 mg/L) or antibiotic,
similarly, deepened crypt depth in the jejunum and
ileum, and also increased villus length in the ileum (May
et al., 2012). Weaned pigs that received diets contain-
ing a water-soluble HEW lysozyme showed longer villus
but similar crypt depth and VLCDR in the ileum com-
pared with those received control diet with no additive
(Nyachoti et al., 2012).
A well-functioning and healthy gut is the corner-
stone for the optimum performances of poultry. When
the gut function and health are impaired, digestion
and absorption of nutrients are affected and thus the
growth performance might be compromised. AID mea-
surement is a quantitative estimation of nutritional and
physiological phenomena related to digestion capacity
and GI functionality. In the current study, supplemen-
tation of broiler diets with Muramidase 007 linearly
improved AID of CP, EE, and P (P < 0.05) which
might suggest an improvement in the digestion capac-
ity and GI functionality. Even though a phytase was
included in all the diets, muramidase groups showed a
linear improvement in AID of P, which might indicate
that muramidase could synergistically enhance phytase
activity. To our best knowledge, there is no data
available evaluating the impact of muramidase (micro-
bial and non-microbial) inclusion in broiler diets on AID
of nutrients. However, just recently Ma et al. (2017)
studied the inclusion of 1 g/kg HEW lysozyme into
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barrows diets and showed no effect on apparent to-
tal tract digestibility of gross energy, DM, and CP.
It is noteworthy that inclusion of HEW lysozyme in
pig and poultry diets has shown beneficial impacts
on the gut health, integrity, microbiota, and antioxi-
dant status as well as intestinal barrier and nonspe-
cific immunity (Liu et al., 2010; Oliver and Wells, 2015;
Long et al., 2016; Abdel-Latif et al., 2017; Gong et al.,
2017; Lichtenberg et al., 2017; Ma et al., 2017), which
could reportedly lead to better digestion and absorption
capacity.
The turnover of the PGNs is a very common path-
way for cell wall recycling of bacteria (Mayer, 2012).
Gram-positive bacteria break down and efficiently re-
cycle approximately 60% of the mature PGNs of their
side wall during cell elongation and approximately 30%
of newly deposited septal PGNs during cell division.
During the growth and maturation, the PGN polymer
is degraded by different PGN hydrolases, such as mu-
ramidase, glucosamidase, amidase, and peptidases (pro-
duced by the host and neighboring microbiota). As a
result, muropeptides (breakdown products of bacteria
PGNs) are shed from the cell wall into the gut (Traub
et al., 2006; Wheeler et al., 2014). It has been reported
that muropeptides modulate inflammatory response in
the GI tract (Traub et al., 2006). Thus, it can be spec-
ulated that the hydroxylation of the PGNs by the di-
etary Muramidase 007 and production of muropeptides
could possibly contribute to a modulation of the in-
flammatory response in the GI tract, and thus explain
the benefits observed on the GI health and functional-
ity. Furthermore, it should be taken into account that,
in a normal conventional GI tract environment, where
symbionts are dominant, PGNs can be accumulated
and a PGN-rich condition can be created (Lee and
Hase, 2014). The consequence of PGNs accumulation
on the intestinal lumen remains to be investigated in
detail, but it could be speculated that accumulation of
bacterial cell wall fragments on the surface of the gut
could impair nutrient digestion and absorption and the
dietary muramidase in the present study might have
counteracted this impact.
In conclusion, inclusion of the current microbial mu-
ramidase in broiler diets could improve the digestion ca-
pacity, and subsequently improve growth performance.
Thus, microbial muramidase can be used as an efficient
feed additive in broiler nutrition, although the biologi-
cal mechanisms leading to these beneficial impacts de-
serve to be studied further.
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